Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staffnews2026-06-15T14:23:41+00:00June 15th, 2026|Endpoints News|
Six leaders working on LGBTQ+ inclusion in biopharmanews2026-06-15T14:00:22+00:00June 15th, 2026|Endpoints News|
Socioeconomic background still holding back students in chemistry, RSC report findsnews2026-06-15T13:30:00+00:00June 15th, 2026|Chemistry World|
Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutnews2026-06-15T11:39:34+00:00June 15th, 2026|Endpoints News|
